S E Tett

Summary

Affiliation: University of Queensland
Country: Australia

Publications

  1. ncbi Consumers' experiences and values in conventional and alternative medicine paradigms: a problem detection study (PDS)
    Lynne Emmerton
    The University of Queensland, School of Pharmacy, Brisbane, QLD 4072, Australia
    BMC Complement Altern Med 12:39. 2012
  2. ncbi The Queensland experience of participation in a national drug use evaluation project, Community-Acquired Pneumonia Towards Improving Outcomes Nationally (CAPTION)
    Lisa K Pulver
    School of Pharmacy, Steele Building, University of Queensland, Queensland, Australia
    BMC Pulm Med 9:38. 2009
  3. ncbi Improving the use of benzodiazepines--is it possible? A non-systematic review of interventions tried in the last 20 years
    Alesha J Smith
    University of Queensland, School of Pharmacy, Brisbane, Queensland, 4072, Australia
    BMC Health Serv Res 10:321. 2010
  4. ncbi Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia
    Nadia Barozzi
    School of Pharmacy, University of Queensland, Steele Building, Brisbane, QLD 4072, Australia
    BMC Health Serv Res 8:196. 2008
  5. ncbi Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure
    Susan E Tett
    The University of Queensland, Faculty of Health Sciences, Brisbane, QLD 4072, Australia
    Transplant Rev (Orlando) 25:47-57. 2011
  6. ncbi Clinical pharmacology: opportunities for educating new practitioners--an Australian perspective
    S E Tett
    Faculty of Health Sciences, The University of Queensland, Brisbane, Australia
    Clin Pharmacol Ther 83:921-4. 2008
  7. ncbi A retrospective analysis of mycophenolic acid and cyclosporin concentrations with acute rejection in renal transplant recipients
    P I Pillans
    Department of Medicine, University of Queensland, Princess Alexandra Hospital, Ipswich Road, Woolloongabba QLD 4102, Brisbane, Australia
    Clin Biochem 34:77-81. 2001
  8. ncbi Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants
    C E Staatz
    School of Pharmacy, University of Queensland, Brisbane, Queensland 4072, Australia
    Transplantation 72:1056-61. 2001
  9. ncbi Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients
    C Dansirikul
    School of Pharmacy, University of Queensland, Brisbane, Queensland 4072, Australia
    J Clin Pharm Ther 31:17-25. 2006
  10. ncbi Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis--a prospective, dose ranging study
    S E Tett
    School of Pharmacy, University of Queensland, Brisbane, Australia
    J Rheumatol 27:1656-60. 2000

Collaborators

Detail Information

Publications18

  1. ncbi Consumers' experiences and values in conventional and alternative medicine paradigms: a problem detection study (PDS)
    Lynne Emmerton
    The University of Queensland, School of Pharmacy, Brisbane, QLD 4072, Australia
    BMC Complement Altern Med 12:39. 2012
    ..32 key issues, seven main themes, informed the questionnaire (the quantitative PDS component - 36 statements explored using five-point Likert scales.)..
  2. ncbi The Queensland experience of participation in a national drug use evaluation project, Community-Acquired Pneumonia Towards Improving Outcomes Nationally (CAPTION)
    Lisa K Pulver
    School of Pharmacy, Steele Building, University of Queensland, Queensland, Australia
    BMC Pulm Med 9:38. 2009
    ....
  3. ncbi Improving the use of benzodiazepines--is it possible? A non-systematic review of interventions tried in the last 20 years
    Alesha J Smith
    University of Queensland, School of Pharmacy, Brisbane, Queensland, 4072, Australia
    BMC Health Serv Res 10:321. 2010
    ..The objective of this paper is to explore interventions aimed at improving the prescribing and use of benzodiazepines in the last 20 years...
  4. ncbi Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia
    Nadia Barozzi
    School of Pharmacy, University of Queensland, Steele Building, Brisbane, QLD 4072, Australia
    BMC Health Serv Res 8:196. 2008
    ..The aim of this study was to compare the utilization of non selective NSAID, COX-2 inhibitors and paracetamol between Queensland and Australia...
  5. ncbi Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure
    Susan E Tett
    The University of Queensland, Faculty of Health Sciences, Brisbane, QLD 4072, Australia
    Transplant Rev (Orlando) 25:47-57. 2011
    ..Consideration of the points summarized above should lead to more effective dosage adjustment based on sound applied pharmacokinetic and pharmacodynamic principles...
  6. ncbi Clinical pharmacology: opportunities for educating new practitioners--an Australian perspective
    S E Tett
    Faculty of Health Sciences, The University of Queensland, Brisbane, Australia
    Clin Pharmacol Ther 83:921-4. 2008
    ..However, the new roles do require extra initiatives in providing educational input in clinical pharmacology to take care of future needs. Some of the potential gaps in the process are identified in this article...
  7. ncbi A retrospective analysis of mycophenolic acid and cyclosporin concentrations with acute rejection in renal transplant recipients
    P I Pillans
    Department of Medicine, University of Queensland, Princess Alexandra Hospital, Ipswich Road, Woolloongabba QLD 4102, Brisbane, Australia
    Clin Biochem 34:77-81. 2001
    ..There is evidence that a relationship exists between MPA area under the concentration-time curve (AUC) and rejection. In this study, a retrospective analysis was undertaken of 27 adult renal transplant recipients...
  8. ncbi Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants
    C E Staatz
    School of Pharmacy, University of Queensland, Brisbane, Queensland 4072, Australia
    Transplantation 72:1056-61. 2001
    ..The aim of this study was to investigate the population pharmacokinetics of tacrolimus in pediatric liver transplant recipients and to identify factors that may explain pharmacokinetic variability...
  9. ncbi Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients
    C Dansirikul
    School of Pharmacy, University of Queensland, Brisbane, Queensland 4072, Australia
    J Clin Pharm Ther 31:17-25. 2006
    ....
  10. ncbi Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis--a prospective, dose ranging study
    S E Tett
    School of Pharmacy, University of Queensland, Brisbane, Australia
    J Rheumatol 27:1656-60. 2000
    ..A 6 month prospective randomized double blind study was conducted to investigate hydroxychloroquine dose concentration-effect relationships in people with rheumatoid arthritis...
  11. ncbi Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines
    G J Kyle
    School of Pharmacy, The University of Queensland, St Lucia, Australia
    J Clin Pharm Ther 33:553-9. 2008
    ..Pharmaceuticals are big business, reporting strong market growth year after year. The 'gatekeepers' of this market are prescribers of medicines, who are the major target of pharmaceutical companies, utilizing direct and indirect influences...
  12. ncbi Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients
    C Dansirikul
    School of Pharmacy, The University of Queensland, Brisbane, QLD 4072, Australia
    Br J Clin Pharmacol 60:560-5. 2005
    ....
  13. ncbi Population pharmacokinetics of lamotrigine
    V Chan
    School of Pharmacy, The University of Queensland, Brisbane, Australia
    Ther Drug Monit 23:630-5. 2001
    ..This study of the population pharmacokinetics of lamotrigine in patients using the drug clinically provides useful data and should lead to better dosage individualization for lamotrigine...
  14. ncbi Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use
    R Ostini
    School of Pharmacy, University of Queensland, Brisbane, Australia
    Pharmacoepidemiol Drug Saf 17:1077-90. 2008
    ..To explore clopidogrel use within Australia, investigating geography, age, sex and cardiac stenting rates...
  15. ncbi Opioid analgesic prescribing and use - an audit of analgesic prescribing by general practitioners and The Multidisciplinary Pain Centre at Royal Brisbane Hospital
    L M Nissen
    School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia
    Br J Clin Pharmacol 52:693-8. 2001
    ..This study evaluated the use of and need for opioids in patients attending the Multidisciplinary Pain Centre at the Royal Brisbane Hospital (RBH)...
  16. ncbi Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil
    B Shum
    School of Pharmacy, University of Queensland, Brisbane, Australia
    Br J Clin Pharmacol 56:188-97. 2003
    ....
  17. ncbi A quality improvement initiative to improve adherence to national guidelines for empiric management of community-acquired pneumonia in emergency departments
    Kylie A McIntosh
    Department of Human Services, Statewide Quality Branch, Melbourne, Vic, Australia
    Int J Qual Health Care 23:142-50. 2011
    ....
  18. ncbi Evaluating Australia's National Medicines Policy using geographical mapping
    E E Roughead
    School of Pharmaceutical, Molecular and Biomedical Sciences, University of South Australia, Australia
    Intern Med J 32:66-71. 2002
    ..However, knowledge of the nature and extent of these activities was lacking. A mechanism was required to map the activities to enable their coordination...